BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31425695)

  • 21. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
    Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
    Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features.
    Igawa T; Omote R; Sato H; Taniguchi K; Miyatani K; Yoshino T; Sato Y
    Pathol Res Pract; 2017 Nov; 213(11):1378-1383. PubMed ID: 28974340
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of 4 mantle cell lymphoma cell lines.
    Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
    Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
    Zapata M; Budnick SD; Bordoni R; Li S
    Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases.
    Yatabe Y; Suzuki R; Matsuno Y; Tobinai K; Ichinohazama R; Tamaru J; Mizoguchi Y; Hashimoto Y; Yamaguchi M; Kojima M; Uike N; Okamoto M; Isoda K; Ichimura K; Morishima Y; Seto M; Suchi T; Nakamura S
    Pathol Int; 2001 Oct; 51(10):747-61. PubMed ID: 11881727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
    Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
    Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mantle Cell Lymphoma With Mantle Zone Growth Pattern.
    Yuan J; Li S; Liu X; Su RJ; Chen M; Wu X; Zheng G; Smith LM; Wang L; Li Y; Liu C; Zhou J; Shen Q; Zhang L; Wang E; Xu ML; Pan Z
    Am J Clin Pathol; 2019 Jul; 152(2):132-145. PubMed ID: 31140550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
    Husby S; Ralfkiaer U; Garde C; Zandi R; Ek S; Kolstad A; Jerkeman M; Laurell A; Räty R; Pedersen LB; Pedersen A; Ehinger M; Sundström C; Karjalainen-Lindsberg ML; Delabie J; Clasen-Linde E; Brown P; Cowland JB; Workman CT; Geisler CH; Grønbæk K
    Blood; 2015 Apr; 125(17):2669-77. PubMed ID: 25736311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].
    He X; Li G; Liu W; Lin Y; Li F; Liao D
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):300-4. PubMed ID: 12417084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
    Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
    Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
    Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
    Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.
    Tagawa H; Karnan S; Suzuki R; Matsuo K; Zhang X; Ota A; Morishima Y; Nakamura S; Seto M
    Oncogene; 2005 Feb; 24(8):1348-58. PubMed ID: 15608680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.